Brokers Set Expectations for Opus Genetics FY2025 Earnings
Opus Genetics, Inc. (NASDAQ:IRD – Free Report) – Analysts at HC Wainwright reduced their FY2025 EPS estimates for shares of Opus Genetics in a research report issued to clients and investors on Tuesday, April 1st. HC Wainwright analyst M. Caufield now forecasts that the company will post earnings of ($1.09) per share for the year, […]
